Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02157519 · ClinicalTrials.gov registry record · NA
Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 212
- Enrollment target
NCT02157519: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02157519 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 212 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02157519, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 212 participants
- Enrollment target
Study Summary
Many people treated for cancer receive oral chemotherapy medications for their illness. This means that much of their cancer care occurs at home, away from a traditional oncology care setting. The purpose of this study is to explore how a Smartphone mobile application ("mobile app") can help improve the cancer treatment process in people who are prescribed oral chemotherapy medication. The investigators will explore how well the mobile app helps patients stay connected with their oncology care team, take their oral medications as prescribed, and manage their cancer-related symptoms from home. This study will be done in two phases: 1) a pilot phase to assess the feasibility of a mobile application intervention, and 2) a randomized-controlled trial to test the intervention.
Interventions
- OTHER Mobile Application Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 212 participants |
| Start Date | 2015-02-18 |
| Est. Completion | 2016-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02157519
The ClinicalTrials.gov registry entry for NCT02157519 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 212 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Mobile Application Intervention is the first listed.
NCT02157519 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02157519 about?
NCT02157519 is a clinical study titled "Mobile Application for Improving Symptoms and Adherence to Oral Chemotherapy in Patients With Cancer". Many people treated for cancer receive oral chemotherapy medications for their illness. This means that much of their cancer care occurs at home, away from a traditional oncology care setting. The purpose of this study is to explore how a Smartphone mobile application ("mobile app") can help improve...
What is the current status of trial NCT02157519?
This trial is currently completed. It is a NA study. The enrollment target is 212 participants. The study started on 2015-02-18. Estimated completion is 2016-12-31.
What interventions are being tested in trial NCT02157519?
The interventions under investigation include: Mobile Application Intervention (OTHER).
Who is sponsoring clinical trial NCT02157519?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.